In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Abbott Vascular to license J&J catheter delivery patents

Executive Summary

Johnson & Johnson plans to license Abbott Vascular Devices a large patent portfolio relating to rapid-exchange (RX) cardiovascular catheter delivery systems (and the related drug-eluting stents) and other interventional products. J&J will need to divest the technology if it succeeds in its intention to acquire CV device specialist Guidant and merge it with its own Cordis business.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Product Purchase

Related Companies